eXoZymes (EXOZ)
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for syn...
- Open
- 7.100
- High
- 7.100
- Low
- 6.850
- Prev. Close
- 6.800
- Volume
- 1.31K
- Turnover
- 9.13K
- Avg Price
- 6.993
- Bid/Ask Ratio
- --
- Amplitude
- 3.68%
- 52wk High
- 18.400
- Volume Ratio
- 0.09
- Turnover Ratio
- 0.02%
News
- PUBT · Sep 2 at 11:44 PM
Exozymes CEO Michael Heltzen reports $59,978 common share purchase
- benzinga_article · Aug 20 at 09:06 PM
12 Health Care Stocks Moving In Thursday's After-Market Session
- Quartr · Aug 20 at 08:16 PM
EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization
- TradingView · Aug 13 at 07:51 PM
EXOZYMES INC. 2Q 2026: Revenue $0 Net loss $(5.25M) — 10-Q Summary
